Search

everythinglearnresearchcommunity

for

Search:↓

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Men with BPH should discuss potential sexual side effects with doctors before treatment, as some treatments can affect ejaculation.

PRP helps tissue repair but lacks standard preparation methods.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Women with PCOS are more likely to experience depressive symptoms.

Exosome therapy can safely and effectively restore color to gray hair.

Caffeine may help with hair loss, but more research is needed.

Standardizing light therapy methods could improve spinal cord injury treatment.

3D printed hollow microneedles could effectively treat skin wrinkles with fewer side effects.

Skin pigmentation varies due to genetics, UV exposure, and drugs, with treatments available but requiring medical advice.

Ginkgo biloba has health benefits but also contains toxic compounds, driving interest in its use in medicine and food.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Gut bacteria pathways may help treat hair loss in obese people.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

People with Alopecia Areata are more likely to have prediabetes and obesity.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Curcumin shows promise in reducing pain and inflammation, but more research is needed.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

Hirsutism in GCC countries is influenced by genetics, obesity, and lifestyle, with cultural stigma delaying treatment, highlighting the need for tailored health strategies.